Cargando…

Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers

Abnormalities of fragile histidine triad (FHIT) and TP53 have been found frequently in nonsmall cell lung cancers. In the current study, 263 primary nonsmall cell lung cancers were investigated for the expressions of Fhit and p53 by immunohistochemistry. Marked reduction of Fhit immunoreactivity (&l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Y-L, Wu, C-T, Shih, J-Y, Lee, Y-C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394260/ https://www.ncbi.nlm.nih.gov/pubmed/12865924 http://dx.doi.org/10.1038/sj.bjc.6601041

Ejemplares similares

Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
por: Lee, Y-C, et al.
Publicado: (2004)

Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma
por: Andachi, H, et al.
Publicado: (2002)

WTH3 is a direct target of the p53 protein
por: Tian, K, et al.
Publicado: (2007)

Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer
por: Rollin, J, et al.
Publicado: (2005)

The relationship between aberrant methylation and survival in non-small-cell lung cancers
por: Toyooka, S, et al.
Publicado: (2004)

Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications
por: Iniesta, P, et al.
Publicado: (2004)

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer
por: Kim, D-W, et al.
Publicado: (2008)

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
por: Szybka, M, et al.
Publicado: (2008)

Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer
por: Coe, B P, et al.
Publicado: (2006)

Investigations on a clinically and functionally unusual and novel germline p53 mutation
por: Rutherford, J, et al.
Publicado: (2002)

Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma
por: Iijima, H, et al.
Publicado: (2004)

Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1β and hypoxia in small cell lung cancer
por: Zhu, Y M, et al.
Publicado: (2006)

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222
por: Enciso-Mora, V, et al.
Publicado: (2013)

Detection and genetic characterization of the novel torque teno virus group 6 in Taiwanese general population
por: Hsiao, Kuang-Liang, et al.
Publicado: (2021)

Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
por: Belinsky, S A, et al.
Publicado: (2007)

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
por: Seng, T J, et al.
Publicado: (2008)

Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer
por: Xing, J, et al.
Publicado: (2008)

Aberrant FHIT transcripts in hepatocellular carcinomas.
por: Chen, Y. J., et al.
Publicado: (1998)

The R72P P53 mutation is associated with familial breast cancer in Jewish women
por: Ohayon, T, et al.
Publicado: (2005)

Study of seven single-nucleotide polymorphisms identified in East Asians for association with obesity in a Taiwanese population
por: Huang, Wei-Hsin, et al.
Publicado: (2016)

Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade
por: Ding, S L, et al.
Publicado: (2004)

Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells
por: Henderson, L-J, et al.
Publicado: (2005)

Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation
por: Berrieman, H K, et al.
Publicado: (2004)

Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
por: Marchetti, A., et al.
Publicado: (1998)

Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance
por: Bowden, Anne Ramsay, et al.
Publicado: (2020)

Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology
por: Jenkins, G J S, et al.
Publicado: (2003)

Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas
por: Shinoura, N, et al.
Publicado: (2002)

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours
por: Krona, C, et al.
Publicado: (2004)

Comprehensive characterization of pharmacogenes in a Taiwanese Han population
por: Lu, Hsing-Fang, et al.
Publicado: (2022)

Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum
por: Chang, Y-C, et al.
Publicado: (2002)

Genetic and epigenetic analyses of MBD3 in colon and lung cancer
por: Zhu, Y, et al.
Publicado: (2004)

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
por: Chen, H-C, et al.
Publicado: (2009)

Restored expression of Fhit protein in Fhit-minus breast cancer cells
por: Campiglio, M, et al.
Publicado: (2001)

Abnormalities of the FHIT gene in human oral carcinogenesis
por: Tanimoto, K, et al.
Publicado: (2000)

B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P
por: Inoue, A, et al.
Publicado: (2015)

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
por: Ying, J, et al.
Publicado: (2009)

Activity (transcription) of the genes for MLH1, MSH2 and p53 in sporadic colorectal tumours with micro-satellite instability
por: Tou, S I H, et al.
Publicado: (2004)

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers
por: Osorio, A, et al.
Publicado: (2008)

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
por: Smith, S L, et al.
Publicado: (2005)

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy
por: Fidler, M J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3aehqoli7ma04poljfqjgp5k3u